In the future, if a larger sample size of patients with ovarian cancer was detected for the La protein, richer data of La expression would be obtained, and a comprehensive statistical correlation analysis would be carried out with the pathological diagnosis and other biochemical tests of patients. This evidence concerns the gene SSB and ovarian carcinoma.